Reacta Healthcare, a clinical diagnostic company dedicated to providing innovative diagnostics for life-threatening food allergies,...
Reacta Healthcare Press Release – 30 January 2024 Reacta Healthcare is a diagnostics company...
Reacta Healthcare Press Release – 23 November 2023 Reacta Healthcare bolsters Board & Executive...
Reacta Healthcare appoints Kevin Hawkins as Head of Regulatory Affairs 20 June 2023, Deeside, United...
Reacta Healthcare is proud to partner with FAACT to support the needs of the food...
Reacta Healthcare is helping combat food allergies amongst paediatrics, addressing the unmet need for greater...
Reacta Healthcare has appointed a new quality control manager to further expand and develop its...
By Dr Martin Wickham, Chief Commercial Officer, Reacta Healthcare Last month I had the...
The Development Bank of Wales has invested £2.4m of equity into ten of Wales’ most...
Reacta Healthcare, based in Deeside North Wales, has secured its first US patent, expanding patents...
Praetura Ventures, the Manchester-based VC firm, has led a £2.9m funding round to support a...
Pursuant to a capital raise in 2020, Reacta has achieved its goal of securing an...
Deeside-based Reacta Biotech is on course to secure a market authorisation for its peanut diagnostic...
The £1 million grant will support the development of the first Oral Food Challenges (OFCs)...
We share relevant third party stories on our website. This release was written and issued...